# Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers.

> **NCT03816228** · — · WITHDRAWN · sponsor: **Tammie L. S. Benzinger, MD, PhD**

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** F 18 T807 Flortaucipir

## Key facts

- **NCT ID:** NCT03816228
- **Lead sponsor:** Tammie L. S. Benzinger, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01
- **Primary completion:** 2022-10-11
- **Final completion:** 2022-10-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** We will capture subjects under another study
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03816228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03816228, "Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers.". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03816228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*